|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1225 NEW YORK AVE. NW |
Address2 | 8th floor |
City | WASHINGTON |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 14108-12
|
||||||||
|
6. House ID# 300450000
|
TYPE OF REPORT | 8. Year | 2023 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Jane Sheehan |
Date | 7/20/2023 6:33:35 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
HR 3417Facilitating Accountability in Reimbursements (FAIR) Act legislation would separate NPIs for off-campus HOPDs; Off-campus OPDs are considered subparts of a provider; Services rendered must be billed to this NPI; HHS may conduct compliance reviews of the requirements made law by this bill
HR2856Combatting Hospital Monopolies ActLegislation that fixes FTC oversight jurisdiction loophole to include nonprofit hospitals
S1451Healthy Competition for Better Care ActLegislation to ban anticompetitive contracting clauses between providers and insurers
TBD/Not yet introducedCHW Access ActTo amend titles XVIII and XIX of the Social Security Act to increase access to community health workers under the Medicare and Medicaid programs.
TBDASSIST Act this legislation would establish a new grant program at HHS to hire and retain mental health providers in schools and includes a 90% increase in federal matching funds to pay for those services.
S. 423Easy Enrollment in Health Care Act This bill revises the procedures related toenrollmentin health insurance affordability programs, including Medicaid, the Children's Health Insurance Program (CHIP), and state-operated Basic Health Programs. The bill provides funding to support the changes.
HR 824Telehealth Benefit Expansion for Workers Act of 2023To amend title XXVII of the Public Health Service Act, the Employee Retirement Income and Security Act of 1974, and the Internal Revenue Code of 1986 to treat benefits for telehealth services offered under a group health plan or group health insurance coverage as excepted benefit
HR 2813Self-Insurance Protection Act To amend the Employee Retirement Income Security Act of 1974, the Public Health Service Act, and the Internal Revenue Code of 1986 to exclude from the definition of health insurance coverage certain medical stop-loss insurance obtained by certain plan sponsors of group health plans, and for other purposes.
HR 2868Association Health Plans ActTo amend the Employee Retirement Income Security Act of 1974 to clarify the treatment of certain association health plans as employers, and for other purposes.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jane |
Sheehan |
|
|
|
Jennifer |
Taylor |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
HR 3305Black Maternal Health Momnibus ActTo end preventable maternal mortality, severe maternal morbidity, and maternal health disparities in the United States, and for other purposes.
HR 3561PATIENT Act"-Codifies the Hospital Price Transparency Rule by amending statutory basis for the rule to explicitly require disclosure of negotiated rates in dollar amounts.
-Increases the maximum penalty for noncompliance to $5 million per year, allows HHS to further increase penalties after 2025.
-Eliminates the price estimator loophole in 2025.
-Directs HHS to implement a uniform method and format for hospitals to post data.
-Directs HHS to regularly monitor hospital compliance and publicly report on warning letters, corrective action plans, and fines.
-Codifies the Transparency in Coverage rule; Starting 2024 - health provider entities must submit annually to HHS the following: Data on mergers/acquisitions, business structure of any parent companies
If the entity is or includes a hospital, it must also report: Average debt-to-earnings ratio, average amount of debt incurred, real estate leases and purchases, and capital gains investments (if non-profit)
- Starting 2025 - HHS will post online a report on this information, and audit/punish those who fail to report. Starting 2024 - health provider entities must submit annually to HHS the following: Data on mergers/acquisitions, business structure of any parent companies
If the entity is or includes a hospital, it must also report: Average debt-to-earnings ratio, average amount of debt incurred, real estate leases and purchases, and capital gains investments (if non-profit)
- Starting 2024 with 4 year phase-in - Drug administration OPD services furnished off-campus will be subject to ASC rates rather than OPPS rates.
HHS will not take into account any resulting reduction in expenditures for budget neutrality adjustments Starting 2024 with 4 year phase-in - Drug administration OPD services furnished off-campus will be subject to ASC rates rather than OPPS rates.
"
S 1869Site-based invoicing and Transparency Enhancement (SITE) ACTLegislation expanding site neutral payments and preventing dishonest billing
Legislation implementing site-neutral payment policies across the board as recommended by MedPACxix, and to eliminate site-dependent reimbursement distortions that indirectly incentivize acquisition of non-hospital patient access points
R2863Preventing Hospital Overbilling of Medicare Act Legislation that - Redefines off-campus oupatient department of a provider to refer to only those departments not located on or within the distance of a hospital facility.; Removes site-neutral exception for off-campus emergency departments; Clarifies secretarial authority to promote site-neutral payments; Also ensures separate NPIs for off-campus outpatient departments of a provider; Requires off-campus departments of providers to charge for services using the separately established NPI
TBD/Not yet introducedAdvancing Maternal Health Equity Under Medicaid Act This bill provides a 90% federal matching rate forMedicaidmaternalhealthcare expenditures that exceed 2021 levels. Qualifying services must be provided by maternity care providers or perinatalhealthworkers (e.g., doulas) and include prenatal and postpartum telehealthservices, home visits, and behavioralhealthcare.
H.R. 561The Equal Access to Abortion Coverage in Health Insurance Act of 223To require federal health care programs to provide coverage for abortion services.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jane |
Sheehan |
|
|
|
Jennifer |
Taylor |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
HR 2679The PBM Accountability ActTo amend the Public Health Service Act, the Employee Retirement Income Security Act, and the Internal Revenue Code of 1984 to increase oversight of pharmacy benefits manager services, and for other purposes
S. 1067Ensuring Timely Access to Generics Act of 2023To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions.
S. 1114Expanding Access to Low-Cost Generics Act of 2023To amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period.
S. 1339Pharmacy Benefit Manager Reform Act To provide for increased oversight of entitiesthat provide pharmacy benefit managementserviceson behalf of group health plansand health insurance coverage.
S. 954Affordable Insulin Now Act of 2013To provide for appropriate cost-sharing forinsulinproducts covered under private health plans, and to establish a program to support health care providers and pharmacies in providing discountedinsulinproducts to uninsured individuals.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jane |
Sheehan |
|
|
|
Jennifer |
Taylor |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |